The safety risks of innovation: the FDA's Expedited Drug Development Pathway
- PMID: 22948694
- DOI: 10.1001/jama.2012.9658
The safety risks of innovation: the FDA's Expedited Drug Development Pathway
Comment in
-
Expedited review of new drugs.JAMA. 2013 Jan 16;309(3):236-7. doi: 10.1001/jama.2012.56911. JAMA. 2013. PMID: 23321756 No abstract available.
-
Expedited review of new drugs--reply.JAMA. 2013 Jan 16;309(3):237. doi: 10.1001/jama.2012.56920. JAMA. 2013. PMID: 23321757 No abstract available.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical